Vertical Peak Holdings Inc (SPLIF)
0.004
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Vertical Peak Holdings Profit Margin (Quarterly): -41.02% for April 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2023 | -41.02% |
| January 31, 2023 | -75.54% |
| October 31, 2022 | -92.85% |
| July 31, 2022 | -653.6% |
| April 30, 2022 | -416.9% |
| January 31, 2022 | -91.93% |
| October 31, 2021 | -128.4% |
| July 31, 2021 | |
| April 30, 2021 | -13.56K% |
| January 31, 2021 | |
| October 31, 2020 |
| Date | Value |
|---|---|
| July 31, 2020 | |
| April 30, 2020 | -187.8% |
| January 31, 2020 | -150.6% |
| October 31, 2019 | -48.29% |
| July 31, 2019 | -219.2% |
| April 30, 2019 | -158.8% |
| January 31, 2019 | -111.8% |
| October 31, 2018 | 20.67% |
| July 31, 2018 | -91.35% |
| April 30, 2018 | -135.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-13.56K%
Minimum
Apr 2021
-41.02%
Maximum
Apr 2023
-1.22K%
Average
-150.6%
Median
Jan 2020
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -109.3% |
| Return on Invested Capital | -342.9% |
| Gross Profit Margin (Quarterly) | 75.23% |
| Operating Margin (Quarterly) | -54.55% |
| Return on Net Operating Assets | -109.3% |